Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index Global is up a healthy 1.18% in October, 3.20% YTD

Monday, November 04, 2013
Opalesque Industry Update - The UCITS Alternative Index Global is up a healthy 1.18% in October 2013 and reaches 3.20% since the beginning of the year. As for last month, the good performance is explained by the strong results of long/short equity managers up 1.85% on average. However the best performing strategy index in October is the UAI CTA up 2.20%. The UAI Multi-Strategy, UAI Emerging Markets and UAI Macro are also up more than 1%. Commodities and Volatility are the only two strategies displaying negative performance for the month with -0.46% and -0.43%.

Since the beginning of the year the UAI Long/Short Equity returns the best performance with a progression of 8.94%. Coming next are the UAI Multi-Strategy Index and the UAI Event-Driven up respectively 3.71% and 3.44%. On the negative side the UAIX Volatility displays the worst performance for the year with -3.77%.

Funds of funds also enjoy a positive month of October with a progression of 0.86% for the UAI Fund of Funds and bringing its year to date performance to 3.38%.

UAIX Indices
With the exception of three, all UAIX indices return positive performance in October. The best results are delivered by the UAIX Long/Short Equity up 2.39% followed by the UAIX CTA, up 1.47%. With a performance of 11.67%, the UAIX Long/Short is in double figures for the time this year. It is followed by the UAIX Event-Driven up 6.03% and the UAIX Multi-Strategy up 3.44%.

UAI Blue Chip
The UAI Blue Chip progresses by 0.81% in October and is up 2.86% for 2013. The best performance is achieved by long/short equity, CTA, and multi-Strategy funds with progressions of 1.65%, 1.23% and 1.16%. On the negative side the worst performing results are achieved by the volatility, commodities and FX funds down -1.33%, -1.11% and -0.89% respectively. The long/short equity bucket is by far the largest contributor to the monthly performance with 33bp. It is followed by the macro and multi-Strategy one with 15bp and 12bp.

AUM and number of funds
The total assets managed in UCITS absolute return fund continue advance in October and now reaches EUR 174.7 billion for single funds and EUR 4.5 billion for funds of funds. The largest monthly growth is achieved by long/short equity funds with inflows of EUR 981 million (or 5.71%). The two strategies that are experiencing the largest outflows are Volatility and CTA with a drop of assets equivalent to -7.68% and -4.56%.


The UCITS Alternative Index series is the industry's leading benchmark for the UCITS absolute return funds universe. The UCITS Alternative Index series of indices track the performance of both global and strategy specific UCITS absolute return funds. Index rules and statistics are accessible on the UCITS Alternative Index website www.ucits-alternative.com. UCITS Alternative Index is a registered trademark. Alix Capital is the exclusive Index Provider to the UCITS Alternative Index.

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its